Lista de obras -

A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet

artículo científico publicado en 2010

A study to evaluate the safety, tolerability, and efficacy of brodalumab in subjects with rheumatoid arthritis and an inadequate response to methotrexate

artículo científico publicado en 2015

Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics

scientific article published on 07 May 2020

Assessment of disaster training needs for physicians and other health professionals serving vulnerable populations in Hawai'i.

artículo científico publicado en 2008

Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis

artículo científico publicado en 2014

Building the case for embedding global health security into universal health coverage: a proposal for a unified health system that includes public health

scientific article published in The Lancet

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

artículo científico publicado en 2017

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

artículo científico publicado en 2018

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).

artículo científico publicado en 2017

Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial.

artículo científico publicado en 2017

Costs of current and improved meningitis disease surveillance in Chad.

artículo científico publicado en 2014

Developing a Tool to Cost Gaps in Implementation of IHR (2005) Core Capacities.

artículo científico publicado en 2014

Development of a population pharmacokinetic model for taranabant, a cannibinoid-1 receptor inverse agonist

artículo científico publicado en 2010

Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program

artículo científico publicado en 2015

EXECUTIVE SUMMARY Insights from Cuba’s COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba

artículo científico publicado en 2022

Ebola in the Democratic Republic of the Congo: time to sound a global alert?

artículo científico publicado en 2019

Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases

artículo científico publicado en 2016

Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss

artículo científico publicado en 2007

Effect of a high-calorie, high-fat meal on the bioavailability and pharmacokinetics of PA-824 in healthy adult subjects

scientific article published on 26 August 2013

Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults

artículo científico publicado en 2007

Establishing a Plan of Action Implementing Integrated DiseaseSurveillance in Sudan.

artículo científico publicado en 2015

Evaluating Cost and Performance for Improved Meningitis DiseaseSurveillance in Chad.

artículo científico publicado en 2015

Evaluation of pharmacokinetic interaction between PA-824 and midazolam in healthy adult subjects

artículo científico publicado en 2013

Evaluation of the pharmacokinetic interaction between repeated doses of rifapentine or rifampin and a single dose of bedaquiline in healthy adult subjects

artículo científico publicado en 2014

Examining the Human Element in Lab Biosafety

artículo científico publicado en 2014

FULL TECHNICAL REPORT Insights from Cuba’s COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba

artículo científico publicado en 2022

Fat and energy partitioning: longitudinal observations in leptin-treated adults homozygous for a Lep mutation

artículo científico

Identification and Assessment of Public Health Surveillance Gaps under the IHR (2005).

artículo científico publicado en 2013

Improvement in Psoriasis Signs and Symptoms Assessed by the Psoriasis Symptom Inventory with Brodalumab Treatment in Patients with Psoriatic Arthritis

artículo científico publicado en 2016

NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine

artículo científico publicado en 2007

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

artículo científico publicado en 2006

New Strategy to Monitor and Assess Laboratory Biosafety Programs

artículo científico publicado en 2013

One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures

artículo científico publicado en 2009

Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials

artículo científico publicado en 2017

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

artículo científico publicado en 2015

Phase II dose-ranging trial of the early bactericidal activity of PA-824

artículo científico publicado en 2012

Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis

artículo científico publicado en 2013

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial

scientific article published on 25 January 2017

Reliability and Validity of the Psoriasis Symptom Inventory in Patients With Psoriatic Arthritis

artículo científico publicado en 2015

Response to Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686

artículo científico publicado en 2016

Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days

artículo científico publicado en 2016

The Global Health Security Index: what value does it add?

artículo científico publicado en 2020

The actual and potential costs of meningitis surveillance in the African meningitis belt: Results from Chad and Niger

artículo científico publicado en 2015

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake

artículo científico publicado en 2008

The globalization of risk and risk perception: why we need a new model of risk communication for vaccines

artículo científico publicado en 2012

Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis.

artículo científico publicado en 2014

Transforming Public Health Surveillance Through Open Public Health Information.

artículo científico publicado en 2018

Why do obese patients not lose more weight when treated with low-calorie diets? A mechanistic perspective

artículo científico publicado en 2007

Lista de obras de

A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet

A study to evaluate the safety, tolerability, and efficacy of brodalumab in subjects with rheumatoid arthritis and an inadequate response to methotrexate

Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics

Assessment of disaster training needs for physicians and other health professionals serving vulnerable populations in Hawai'i.

Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis

Building the case for embedding global health security into universal health coverage: a proposal for a unified health system that includes public health

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).

Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial.

Costs of current and improved meningitis disease surveillance in Chad.

Developing a Tool to Cost Gaps in Implementation of IHR (2005) Core Capacities.

Development of a population pharmacokinetic model for taranabant, a cannibinoid-1 receptor inverse agonist

Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program

EXECUTIVE SUMMARY Insights from Cuba’s COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba

Ebola in the Democratic Republic of the Congo: time to sound a global alert?

Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases

Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss

Effect of a high-calorie, high-fat meal on the bioavailability and pharmacokinetics of PA-824 in healthy adult subjects

Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults

Establishing a Plan of Action Implementing Integrated DiseaseSurveillance in Sudan.

Evaluating Cost and Performance for Improved Meningitis DiseaseSurveillance in Chad.

Evaluation of pharmacokinetic interaction between PA-824 and midazolam in healthy adult subjects

Evaluation of the pharmacokinetic interaction between repeated doses of rifapentine or rifampin and a single dose of bedaquiline in healthy adult subjects

Examining the Human Element in Lab Biosafety

FULL TECHNICAL REPORT Insights from Cuba’s COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba

Fat and energy partitioning: longitudinal observations in leptin-treated adults homozygous for a Lep mutation

Identification and Assessment of Public Health Surveillance Gaps under the IHR (2005).

Improvement in Psoriasis Signs and Symptoms Assessed by the Psoriasis Symptom Inventory with Brodalumab Treatment in Patients with Psoriatic Arthritis

NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

New Strategy to Monitor and Assess Laboratory Biosafety Programs

One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures

Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

Phase II dose-ranging trial of the early bactericidal activity of PA-824

Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial

Reliability and Validity of the Psoriasis Symptom Inventory in Patients With Psoriatic Arthritis

Response to Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686

Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days

The Global Health Security Index: what value does it add?

The actual and potential costs of meningitis surveillance in the African meningitis belt: Results from Chad and Niger

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake

The globalization of risk and risk perception: why we need a new model of risk communication for vaccines

Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis.

Transforming Public Health Surveillance Through Open Public Health Information.

Why do obese patients not lose more weight when treated with low-calorie diets? A mechanistic perspective